Recruiting NA Recurrent Anterior Shoulder Instability

New treatment option for Recurrent Anterior Shoulder Instability

Official title Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss

ClinicalTrials.gov ID: NCT07488039

What this study is testing

What it's testing
The goal of this clinical trial is to learn Labroplasty using the long head of biceps tendon works to patients with recurrent anterior shoulder instability with subcritical glenoid bone loss (\<20%) and thinned or deficient anterior labrum .The main questions it aims to answer are: Does Labroplasty using the long head of biceps improve the functional and radiological outcomes in patients with recurrent anterior shoulder instability with subcritical glenoid bone loss? Participants will: undergo arthroscopic labroplasty using the long head of biceps tendon Visit the clinic regularly for checkup and followup undergo MRI at 6 months to check radiological outcome

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 16 and older

You may be able to join if

  • patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation.
  • Franceschi types 2 and 3 labral defects
  • subcritical glenoid bone loss \<20%
  • positive anterior shoulder apprehension

You likely can't join if

  • Critical glenoid bones loss \>20%
  • Franceschi type 1 labral defect
  • concomitant long head of biceps tendon pathology
  • multidirectional instability
  • prior arthroscopic shoulder stabilization surgery
  • concomitant proximal humeral fractures
See the full eligibility criteria
Who can join
  • patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation.
  • Franceschi types 2 and 3 labral defects
  • subcritical glenoid bone loss \<20%
  • positive anterior shoulder apprehension
What rules you out
  • Critical glenoid bones loss \>20%
  • Franceschi type 1 labral defect
  • concomitant long head of biceps tendon pathology
  • multidirectional instability
  • prior arthroscopic shoulder stabilization surgery
  • concomitant proximal humeral fractures
  • concomitant Rotator cuff tears
  • skeletally immature patients
  • glenoid pathology
  • Shoulder arthritis
  • active infection

The study team makes the final eligibility decision.

Where it's taking place

  • Cairo, Cairo Governorate, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.